Skip to main content

1-5 of 5 results for subject:Pfizer

Primary member X
Miller, Andrew

Type

House

Session

Year

Department

Member

Primary member

Miller, Andrew (5)
More

Answering member

Legislative stage

Legislation

Subject

Publisher


Show detailed: On Off
Results: 10 20 50 100
Sort by: Newest first Oldest first

To ask the Secretary of State for Business, Innovation and Skills whether the South East of England Regional Development Agency was (a) consulted and (b) asked to provide its expertise by his Department prior to his decision to establish a taskforce on the closure of Pfizer's site in Kent; and...

Asked by
Andrew Miller (Labour)
Answering body
Department for Business, Innovation and Skills
Type
Written questions
Status
Answered
Date
4 February 2011
Reference
38428; 522 c976W
House
House of Commons

To ask the Secretary of State for Business, Innovation and Skills when he was informed of the decision by Pfizer to close its site in Kent.

Asked by
Andrew Miller (Labour)
Answering body
Department for Business, Innovation and Skills
Type
Written questions
Status
Answered
Date
4 February 2011
Reference
38431; 522 c977W
House
House of Commons

To ask the Secretary of State for Business, Innovation and Skills what estimate his Department has made of the effects on the pharmaceutical industry in the UK of the decision by Pfizer to close its site in Kent

Asked by
Andrew Miller (Labour)
Answering body
Department for Business, Innovation and Skills
Type
Written questions
Status
Answered
Date
4 February 2011
Reference
38429; 522 c976W
House
House of Commons

To ask the Secretary of State for Business, Innovation and Skills what meetings he has had with representatives of Pfizer (a) before and (b) after its decision to close its research and development site in Kent.

Asked by
Andrew Miller (Labour)
Answering body
Department for Business, Innovation and Skills
Type
Written questions
Status
Answered
Date
4 February 2011
Reference
38427; 522 c976W
House
House of Commons

To ask the Secretary of State for Business, Innovation and Skills if he will meet representatives of the Royal Society of Chemistry to discuss the implications for scientific research of the decision by Pfizer to close its site in Kent.

Asked by
Andrew Miller (Labour)
Answering body
Department for Business, Innovation and Skills
Type
Written questions
Status
Answered
Date
4 February 2011
Reference
38430; 522 c976-7W
House
House of Commons